78 related articles for article (PubMed ID: 36389832)
1. COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation.
Shi W; Chen Z; Liu H; Miao C; Feng R; Wang G; Chen G; Chen Z; Fan P; Pang W; Li C
Front Immunol; 2022; 13():937125. PubMed ID: 36389832
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis.
Zheng H; Tan J; Qin F; Zheng Y; Yang X; Qin X; Liao H
BMC Med Genomics; 2024 Apr; 17(1):97. PubMed ID: 38649961
[TBL] [Abstract][Full Text] [Related]
3. Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer.
Nallanthighal S; Heiserman JP; Cheon DJ
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668097
[TBL] [Abstract][Full Text] [Related]
4. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature.
Li X; Li X; Yang B; Sun S; Wang S; Yu F; Wang T
Front Immunol; 2024; 15():1369289. PubMed ID: 38756785
[TBL] [Abstract][Full Text] [Related]
5. A novel compound heterozygous variant of the COL11A1 gene in a patient with fibrochondrogenesis type I: the first case in Korea.
Jeon J; Kim M; Yoo S; Kim Y; Cheon CK
Ann Pediatr Endocrinol Metab; 2024 Apr; 29(2):135-137. PubMed ID: 38712494
[No Abstract] [Full Text] [Related]
6. [COL11A1 regulates PI3K/Akt/GSK-3β pathway and promotes human lung adenocarcinoma primary cell migration and invasion].
Yang SY; Zhu LH; Yang R; Liao TT; Hu XW
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):580-586. PubMed ID: 37278172
[No Abstract] [Full Text] [Related]
7. COL11A1-driven positive feedback loop modulates fibroblast transformation and activates pancreatic cancer progression.
Sun D; Dai T; Ji Y; Shen W; Bian W
Cell Biol Int; 2023 Jun; 47(6):1081-1091. PubMed ID: 36861686
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance.
Leeha M; Kanokwiroon K; Laohawiriyakamol S; Thongsuksai P
Pathol Oncol Res; 2023; 29():1611162. PubMed ID: 37274773
[No Abstract] [Full Text] [Related]
9. Overexpression of COL11A1 confers tamoxifen resistance in breast cancer.
Fu C; Duan S; Zhou X; Meng Y; Chen X
NPJ Breast Cancer; 2024 May; 10(1):38. PubMed ID: 38806505
[TBL] [Abstract][Full Text] [Related]
10. Unveiling Collagen's Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications.
Li X; Jin Y; Xue J
Int J Gen Med; 2024; 17():1773-1787. PubMed ID: 38711825
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.
Zhao D; Guo Y; Wei H; Jia X; Zhi Y; He G; Nie W; Huang L; Wang P; Laster KV; Liu Z; Wang J; Lee MH; Dong Z; Liu K
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652547
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.
Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptors in breast cancer.
Mahdizadeh M; Heydari N; Shafiei A; Akbari H; Jafari SM
Mol Biol Rep; 2024 Mar; 51(1):464. PubMed ID: 38551734
[TBL] [Abstract][Full Text] [Related]
14. The Spherical Evolutionary Multi-Objective (SEMO) Algorithm for Identifying Disease Multi-Locus SNP Interactions.
Ren F; Li S; Wen Z; Liu Y; Tang D
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275593
[TBL] [Abstract][Full Text] [Related]
15. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.
Wu X; Lu W; Zhang W; Zhang D; Mei H; Zhang M; Cui Y; Zhuo Z
Aging (Albany NY); 2023 Nov; 15(21):12674-12697. PubMed ID: 37963845
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer.
Xu R; You T; Liu C; Lin Q; Guo Q; Zhong G; Liu L; Ouyang Q
Front Oncol; 2023; 13():1216446. PubMed ID: 37583930
[TBL] [Abstract][Full Text] [Related]
18. Positive influence of managing cancer and living meaningfully (CALM) on fear of cancer recurrence in breast cancer survivors.
Wang M; Gan C; Zhao J; Li W; Yu S; Yao S; Tang L; Xu J; Cheng H
Am J Cancer Res; 2023; 13(7):3067-3079. PubMed ID: 37559986
[TBL] [Abstract][Full Text] [Related]
19. Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer.
Tian Y; Dong J; Li L
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511974
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with
Wang Q; Liu Y; Li Z; Tang Y; Long W; Xin H; Huang X; Zhou S; Wang L; Liang B; Li Z; Xu M
Front Immunol; 2023; 14():1182277. PubMed ID: 37215115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
